天健会计师事务所（特殊普通合伙） 关于奥比中光科技集团股份有限公司 最近三年及一期非经常性损益的鉴证报告 目 录 一、最近三年及一期非经常性损益的鉴证报告……………………第 1—2 页 二、最近三年及一期非经常性损益明细表…………………………第 3—4 页 三、最近三年及一期非经常性损益明细表附注……………………第 5—7 页 四、报告附件………………………………………………………第 8—12 页 关于奥比中光科技集团股份有限公司 最近三年及一期非经常性损益的鉴证报告 天健审〔2025〕8625 号 奥比中光科技集团股份有限公司全体股东： 我们审核了后附的奥比中光科技集团股份有限公司（以下简称奥比中光公司） 管理层编制的最近三年及一期非经常性损益明细表（2022－2024 年度以及 2025 年 1－3 月）及其附注（以下简称非经常性损益明细表）。 一、对报告使用者和使用目的的限定 五、鉴证结论 我们认为，奥比中光公司管理层编制的非经常性损益明细表在所有重大方面 符合中国证券监督管理委员会《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益（2023 年修订）》（证监会公告〔2023〕65 号）的 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥191,058,207.36, representing a 105.63% increase compared to ¥92,911,484.67 in the same period last year[5] - Net profit attributable to shareholders was ¥24,315,014.74, a significant recovery from a loss of ¥28,780,669.45 in the previous year[5] - Operating profit for Q1 2025 was ¥24,337,813.72, a turnaround from a loss of ¥27,479,953.45 in Q1 2024[19] - Net profit for Q1 2025 was ¥24,165,982.51, compared to a net loss of ¥27,806,552.46 in Q1 2024[19] - The company reported a total comprehensive income of ¥24,148,806.40 for Q1 2025, compared to a loss of ¥27,793,174.36 in Q1 2024[19] - Earnings per share for Q1 2025 were ¥0.06, recovering from a loss of ¥0.07 per share in Q1 2024[19] Cash Flow - The net cash flow from operating activities improved to ¥1,428,459.10, up from a negative cash flow of ¥33,630,208.57 in the same period last year[5] - In Q1 2025, the cash inflow from operating activities was CNY 253,701,888.60, an increase of 48.8% compared to CNY 170,418,034.89 in Q1 2024[22] - The net cash flow from operating activities turned positive at CNY 1,428,459.10 in Q1 2025, compared to a negative CNY 33,630,208.57 in Q1 2024[22] - Cash inflow from investment activities reached CNY 621,116,570.15 in Q1 2025, up from CNY 357,413,857.95 in Q1 2024, marking a 73.6% increase[23] - The net cash flow from investment activities was CNY 178,225,366.00 in Q1 2025, a significant recovery from a negative CNY 80,241,548.02 in Q1 2024[23] - The company incurred CNY 80,758,344.44 in cash outflows from financing activities in Q1 2025, compared to CNY 48,714,255.70 in Q1 2024[23] - The cash flow from financing activities was negative at CNY 40,758,344.44 in Q1 2025, contrasting with a positive CNY 32,330,402.00 in Q1 2024[23] Research and Development - Research and development (R&D) expenses totaled ¥44,949,026.16, a decrease of 16.03% from ¥53,529,171.82 year-on-year[5] - The proportion of R&D expenses to revenue was 23.53%, down by 34.08 percentage points compared to 57.61% in the previous year[5] - Research and development expenses for Q1 2025 were ¥44,949,026.16, down from ¥53,529,171.82 in Q1 2024, reflecting a focus on cost management[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,231,604,367.35, a decrease of 2.93% from ¥3,328,990,861.53 at the end of the previous year[6] - Total liabilities decreased to ¥327,272,299.14 in the latest report from ¥454,710,799.30 in the previous period[20] - Total equity increased to ¥2,904,332,068.21 from ¥2,874,280,062.23, indicating a positive trend in shareholder equity[20] - Shareholders' equity attributable to the parent company increased by 1.06% to ¥2,897,623,676.31 from ¥2,867,303,020.47 at the end of the previous year[6] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,808[11] - The largest shareholder, Huang Yuanhao, holds 108,903,960 shares, representing 27.23% of the total shares[11] Operational Highlights - The significant increase in revenue was primarily driven by rapid growth in AIoT business[10] - The company expects continued growth in revenue and profitability due to increased sales collections and reduced expenses[10] - There are no other important reminders regarding the company's operational situation during the reporting period[13]

第二条 信息披露义务人，是指公司及其董事、高级管理人员、股东、实 际控制人，收购人，重大资产重组、再融资、重大交易有关各方等自然人、单位 及其相关人员，破产管理人及其成员，以及法律、行政法规和中国证监会规定的 其他承担信息披露义务的主体。 第三条 信息披露义务人应当及时依法履行信息披露义务，披露的信息应 当真实、准确、完整，简明清晰、通俗易懂，不得有虚假记载、误导性陈述或者 重大遗漏。 奥比中光科技集团股份有限公司 信息披露管理制度 第一章 总 则 第一条 为进一步规范奥比中光科技集团股份有限公司（以下简称"公司"） 的信息披露行为，加强信息披露事务管理，保护投资者的合法权益，根据《中华 人民共和国公司法》《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理规定》《上海证券交 易所科创板股票上市规则》等法律、法规、规范性文件以及《奥比中光科技集团 股份有限公司章程》（以下简称"《公司章程》"）等有关规定，结合公司实际情况， 制定本制度。 信息披露义务人披露的信息应当同时向所有投资者披露，不得提前向任何单 位和个人泄露。但是，法律、行政法规另有规定的 ...

奥比中光科技集团股份有限公司 董事、高级管理人员离职管理制度 第一章 总 则 第一条 为规范奥比中光科技集团股份有限公司（以下简称"公司"）董事、 高级管理人员离职管理，保障公司治理稳定性及股东合法权益，根据《中华人民 共和国公司法》《上市公司章程指引》和《奥比中光科技集团股份有限公司章程》 （以下简称"《公司章程》"）的规定，制定本制度。 第二条 本制度适用于公司全体董事（含独立董事）及高级管理人员的辞任、 任期届满、解任以及其他导致董事、高级管理人员实际离职等情形。 第二章 离职情形与生效条件 第三条 董事可以在任期届满以前辞任。董事辞任应向董事会提交书面辞职 报告，公司收到辞职报告之日辞任生效，公司将在两个交易日内披露有关情况。 第四条 如存在以下情形的，在改选出的董事就任前，原董事仍应当依照法 律、行政法规、部门规章和《公司章程》规定，履行董事职务，但存在相关法规 另有规定的除外： （一）董事辞职导致董事会成员低于法定最低人数； （二）审计委员会成员辞职导致审计委员会成员低于法定最低人数，或者欠缺 会计专业人士； （三）独立董事辞职导致董事会或者其专门委员会中独立董事所占比例不符合 法律、行政法规或者 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [2][5]. Core Views - The company has shown a revenue growth of over 50% in 2024, with a significant reduction in losses by more than 70% due to effective cost control [4][8]. - The company is launching three new AI vision products tailored for different robotic applications, indicating a positive operational outlook [4][5]. - The revenue forecast for 2025, 2026, and 2027 is projected at RMB 906 million, RMB 1.247 billion, and RMB 1.523 billion respectively, with corresponding price-to-sales ratios of 26.2, 19.0, and 15.6 times [5][7]. Summary by Sections Stock Performance - The company's stock has shown an absolute increase of 31.0% year-to-date and 140.3% over the past 12 months, outperforming the Shanghai Composite Index by 29.9% and 131.9% respectively [3]. Financial Performance - The company reported a main revenue of RMB 564 million in 2024, a year-on-year increase of 56.8%, with a net loss of RMB 63 million, a reduction of 77.2% compared to the previous year [8]. - The gross margin for 2024 was 41.8%, a slight decrease of 0.9 percentage points year-on-year, while the net margin improved significantly by 65.4 percentage points to -11.1% [8]. Product Development - The company has introduced several new products, including the Orbbec Gemini 335 and 336 series, designed for 3D vision in robotics, and the Orbbec MS 600 laser radar, which enhances environmental perception for robots [8]. Market Outlook - The report highlights the company's strong position in the 3D vision perception market, anticipating growth opportunities in the robotics industry [5][8].

Core Insights - The first humanoid robot half marathon held in Beijing has significantly increased interest in the humanoid robot industry, with the "Tiangong Ultra" robot winning the race in 2 hours, 40 minutes, and 42 seconds, reshaping perceptions of humanoid robot capabilities [1] - The event highlighted the supply chain behind the winning robot, revealing various listed companies' involvement, although no direct collaborations with Tiangong were confirmed [2][3] Group 1: Company Developments - The Tiangong robot was developed by the Beijing Humanoid Robot Innovation Center, established in November 2023, with key stakeholders including UBTECH, Xiaomi Robotics, and Beijing Electromechanical, each holding a 28.57% stake [1] - Following the competition, UBTECH announced the establishment of a wholly-owned subsidiary in Beijing to commercialize and globally sell the Walker and Tiangong series humanoid robots [1] Group 2: Supply Chain and Partnerships - Several listed companies, including Shuanglin Co., Liancheng Precision, Honggong Technology, and others, responded to inquiries about Tiangong but did not confirm any partnerships [2][3] - The main suppliers for Tiangong include Aobo Zhongguang, which provides 3D vision sensors, and Lide Harmonic, which supplies harmonic reducers [3][4] Group 3: Technical Challenges - The humanoid robot industry faces significant technical challenges, as evidenced by the low completion rate of less than 30% in the marathon, with issues such as falls and joint overheating being prevalent [6][7] - Key areas needing improvement include high-density battery packs, low-power motor drivers, and robust algorithms for dynamic obstacle recognition and path planning [7]

Core Insights - The humanoid robot industry is on the brink of commercialization, with companies like SUTENG and ORBBE focusing on advanced vision solutions [1] - SUTENG emphasizes laser radar for 3D environmental perception, while ORBBE specializes in 3D vision sensors for close-range object recognition [1] - Both companies adopt a "co-opetition" strategy, combining competition and collaboration in the multi-sensor fusion approach [1] Company Strategies - ORBBE launched the Gemini 335/336 series depth cameras and MS600 laser radar, covering various technical routes to meet humanoid robot environment modeling needs [2] - In 2024, ORBBE reported revenue of 564 million yuan, a 56.8% increase year-on-year, while net profit loss decreased by 77.20% [2] - SUTENG aims to be a "robot technology platform company," launching new products like the Active Camera platform and the second-generation dexterous hand [2][3] - SUTENG achieved revenue of 1.649 billion yuan in 2024, a 47.20% increase, with a net loss of 482 million yuan, reducing losses by 88.89% [3] Competitive Landscape - The competition between ORBBE and SUTENG is characterized by short-term implementation capabilities versus long-term technological barriers [4] - ORBBE's 3D vision sensors have established a scalable delivery capability, partnering with leading robot clients like Cloudwise Technology and Qianlong Intelligent [4][5] - SUTENG invested 615 million yuan in R&D in 2024, accounting for 37.3% of total revenue, while ORBBE invested 204 million yuan, making up 36.2% [4] - SUTENG's strategy includes a low-price approach to market expansion, aiming for a "low-cost hardware + value-added services" business model [5] Industry Trends - The humanoid robot sector is entering a new phase of "soft and hard collaboration," with ORBBE's rapid implementation capabilities meeting initial industry demands [5] - The next two years will be crucial for determining which company can achieve breakthroughs in cost control and scene adaptability, potentially leading the value chain distribution in the next robot era [5]

Group 1 - The core viewpoint highlights the ongoing decline of the Shanghai Stock Exchange Sci-Tech Innovation Board Artificial Intelligence Index, which fell by 1.23% as of April 22, 2025, with mixed performance among constituent stocks [3] - The AI application landscape is accelerating, with significant releases from OpenAI, including the GPT-4.1 series and enhancements in AI capabilities, indicating a robust growth trajectory in AI technologies [3] - The Sci-Tech AI ETF closely tracks the performance of the Shanghai Stock Exchange Sci-Tech Innovation Board Artificial Intelligence Index, which comprises 30 large-cap companies providing foundational resources and technologies for AI [4] Group 2 - The report from Guotai Junan Securities emphasizes the broad application of AI across various sectors, including securities research, banking, and insurance, suggesting a promising future for companies developing specialized AI models and products [4] - The Sci-Tech AI ETF has seen a significant growth in scale, increasing by 21.80 billion in the last three months, ranking it among the top in its category [4] - The ETF has also experienced a notable increase in shares, with a growth of 3,600,000 shares in the past month, placing it in the middle tier of comparable funds [4] Group 3 - Leveraged funds are increasingly investing in the Sci-Tech AI ETF, which recorded a net purchase of 1.1618 million in financing this month, indicating strong investor interest [5] - The ETF has demonstrated strong performance metrics, with a maximum monthly return of 15.59% since inception and a historical three-month holding profitability rate of 93.33% [5] - The management fee of the Sci-Tech AI ETF is competitive at 0.50%, with a custody fee of 0.10%, making it one of the lowest in its category [5] Group 4 - The top ten weighted stocks in the Sci-Tech Innovation Board Artificial Intelligence Index include companies like Lanke Technology and Chip Original, with the top ten collectively accounting for a significant portion of the index [7]

公募基金方面本期较上一季度持股减少的公募基金共计4个，包括中银证券优势制造股票A、中银证券 新能源混合A、金信多策略精选混合A、东财景气驱动混合发起式A，持股减少占比小幅下跌。本期较 上一季度新披露的公募基金共计193个，主要包括兴全合润混合A、招商优势企业混合A、兴全商业模式 混合(LOF)A、兴全合宜混合A、兴全新视野定期开放混合型发起式等。本期较上一季未再披露的公募基 金共计1个，即天弘国证2000指数增强A。 2025年4月22日，奥比中光(688322.SH)发布2024年年度报告。截至2025年4月21日，共有206个机构投资 者披露持有奥比中光A股股份，合计持股量达1.27亿股，占奥比中光总股本的31.65%。其中，前十大机 构投资者包括上海云鑫创业投资有限公司、珠海奥比中芯投资合伙企业(有限合伙)、招商银行股份有限 公司-兴全合润混合型证券投资基金、美的创新投资有限公司、前海仁智互联(深圳)股权投资企业(有限 合伙)、中国银行股份有限公司-招商优势企业灵活配置混合型证券投资基金、兴全商业模式混合 (LOF)A、兴全合宜混合A、兴全新视野定期开放混合型发起式、博时科创100ETF，前十大机构投资 ...